Products & Services · Revenues:

All other Specialty Care — Revenues:

Pfizer All other Specialty Care — Revenues: increased by 21.6% to $579.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $486.00M to $579.00M. Over 2 years (FY 2023 to FY 2025), All other Specialty Care — Revenues: shows an upward trend with a 14.1% CAGR.

Analysis

StatementSegment
First reportedQ1 2020
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_all_other_specialty_care_revenues

Historical Data

18 periods
 Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$702.00M$696.00M$643.00M$586.00M$575.00M$188.00M$185.00M$202.00M$775.00M$513.00M$429.00M$323.00M$344.00M$486.00M$390.00M$407.00M$476.00M$579.00M
QoQ Change-0.9%-7.6%-8.9%-1.9%-67.3%-1.6%+9.2%+283.7%-33.8%-16.4%-24.7%+6.5%+41.3%-19.8%+4.4%+17.0%+21.6%
YoY Change-18.1%-70.8%-68.4%-64.9%+172.9%+131.9%+59.9%-55.6%-5.3%-9.1%+26.0%+38.4%+19.1%
Range$185.00M$775.00M
CAGR-4.4%
Avg YoY Growth+12.0%
Median YoY Growth-5.3%
Current Streak3 quarters growth

Frequently Asked Questions

What is Pfizer's all other specialty care — revenues:?
Pfizer (PFE) reported all other specialty care — revenues: of $579.00M in Q1 2026.
How has Pfizer's all other specialty care — revenues: changed year-over-year?
Pfizer's all other specialty care — revenues: increased by 19.1% year-over-year, from $486.00M to $579.00M.
What is the long-term trend for Pfizer's all other specialty care — revenues:?
Over 2 years (2023 to 2025), Pfizer's all other specialty care — revenues: has grown at a 14.1% compound annual growth rate (CAGR), from $1.35B to $1.76B.